AEON Biopharma approves 1-for-72 reverse stock split to maintain NYSE American listing

AEON Biopharma, Inc.

Reverse split ratio of 1-for-72; effective 12:01 AM ET on February 26, 2025.
Outstanding shares reduced from ~79.9 million to ~1.1 million; fractional shares rounded up.
Authorized shares increased from 500 million to 1.04 billion at special meeting.
Ticker 'AEON' unchanged; new CUSIP 00791X 209; votes: 32.6M for, 3.6M against.
Purpose: increase share price to comply with NYSE American continued listing standards.

item 3.03 item 5.03 item 5.07 item 7.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.